Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Azenta Life Sciences, often simply known as Azenta, is a US-headquartered global provider of comprehensive solutions for the life science industry. Evolving from Brooks Automation in 2021, the company has swiftly established itself as a trusted partner in advancing scientific discovery and development worldwide.
Azenta specialises in critical areas including automated sample management, industry-leading genomic services, and high-quality cryogenic consumables. Their integrated product and service portfolio delivers unparalleled precision and reliability, essential for drug discovery, clinical development, and cutting-edge research in cell and gene therapy and biobanking. These innovative laboratory solutions empower researchers to accelerate breakthroughs and drive the future of medicine.
+26 vs industry average
Azenta Life Science’s score of 48 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Health Services has typical carbon intensity
The Health Services industry has reduced its overall emissions by 23% since 2018
Scope 3 accounts for ••• of total emissions.
Azenta Life Sciences reported approximately 91.15 million kg CO2e in total emissions for 2025. This includes about 4.00 million kg CO2e from Scope 1, approximately 6.85 million kg CO2e from Scope 2 (market-based), and roughly 80.30 million kg CO2e from Scope 3.
In 2024, Azenta Life Sciences' Scope 1 emissions were about 4.15 million kg CO2e, and Scope 2 emissions (market-based) were approximately 9.99 million kg CO2e. For 2023, Scope 1 emissions were roughly 4.51 million kg CO2e, and Scope 2 emissions (market-based) were about 10.57 million kg CO2e. In 2022, Scope 1 emissions were approximately 4.65 million kg CO2e, and Scope 2 emissions (market-based) were about 13.49 million kg CO2e.
Azenta Life Sciences is committed to reducing its Scope 1 and 2 GHG emissions by 55% by 2033, against a 2022 base year. The company has also made a long-term net-zero commitment with the Science Based Targets initiative (SBTi) for all scopes by 2050. However, their near-term SBTi commitment has been removed as of February 2024.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Azenta Life Science’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more